Industry: Medical Devices & Consumables
Published Date: 2026-03-12
Pages: 119 Pages
Report ld: 6220459
Request Sample
Customized Report
Hematology Controls and Calibrators Market Size(US$)

CAGR 2026-2032
6.2%
Market Size,2032
USD 719
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hematology Controls and Calibrators market was valued at US$ 475 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hematology Controls and Calibrators competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hematology Controls and Calibrators are standard substances used to ensure the accuracy and reliability of blood analyzer (such as blood routine testing equipment) test results. Controls simulate the cellular components of real blood samples, such as red blood cells, white blood cells, and platelets, and are used for daily monitoring of instrument performance stability, such as precision and accuracy; Calibrators are specific analytes with known concentrations (such as hemoglobin, MCV) used to calibrate instrument detection parameters and eliminate systematic errors.
The North American market for Hematology Controls and Calibrators is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Hematology Controls and Calibrators is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Hematology Controls and Calibrators include Bio-Rad, Streck, Thermo Fisher Scientific, Randox Laboratories, Sysmex, Fortress Diagnostics, Bio-Techne, Diatron, Changchun DIRUI, Shenzhen Mindray, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Hematology Controls and Calibrators market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hematology Controls and Calibrators. The Hematology Controls and Calibrators market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hematology Controls and Calibrators market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hematology Controls and Calibrators manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Hematology Controls and Calibrators manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Hematology Controls and Calibrators sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hematology Controls and Calibrators Market Overview
1.1 Product Definition
1.2 Hematology Controls and Calibrators by Type
1.2.1 Global Hematology Controls and Calibrators Market Value by Type: 2025 vs 2032
1.2.2 High Level
1.2.3 Medium Level
1.2.4 Low Level
1.3 Hematology Controls and Calibrators by Application
1.3.1 Global Hematology Controls and Calibrators Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Laboratory
1.4 Global Hematology Controls and Calibrators Market Size Estimates and Forecasts
1.4.1 Global Hematology Controls and Calibrators Revenue 2021–2032
1.4.2 Global Hematology Controls and Calibrators Sales 2021–2032
1.4.3 Global Hematology Controls and Calibrators Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Hematology Controls and Calibrators Market Competition by Manufacturers
2.1 Global Hematology Controls and Calibrators Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hematology Controls and Calibrators Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hematology Controls and Calibrators Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hematology Controls and Calibrators, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hematology Controls and Calibrators, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hematology Controls and Calibrators, Product Types and Applications
2.7 Global Key Manufacturers of Hematology Controls and Calibrators, Date of Entry into the Industry
2.8 Global Hematology Controls and Calibrators Market Competitive Situation and Trends
2.8.1 Global Hematology Controls and Calibrators Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hematology Controls and Calibrators Players Market Share by Revenue
2.8.3 Global Hematology Controls and Calibrators Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hematology Controls and Calibrators Market Scenario by Region
3.1 Global Hematology Controls and Calibrators Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hematology Controls and Calibrators Sales by Region: 2021–2032
3.2.1 Global Hematology Controls and Calibrators Sales by Region: 2021–2026
3.2.2 Global Hematology Controls and Calibrators Sales by Region: 2027–2032
3.3 Global Hematology Controls and Calibrators Revenue by Region: 2021–2032
3.3.1 Global Hematology Controls and Calibrators Revenue by Region: 2021–2026
3.3.2 Global Hematology Controls and Calibrators Revenue by Region: 2027–2032
3.4 North America Hematology Controls and Calibrators Market Facts & Figures by Country
3.4.1 North America Hematology Controls and Calibrators Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hematology Controls and Calibrators Sales by Country (2021–2032)
3.4.3 North America Hematology Controls and Calibrators Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hematology Controls and Calibrators Market Facts & Figures by Country
3.5.1 Europe Hematology Controls and Calibrators Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hematology Controls and Calibrators Sales by Country (2021–2032)
3.5.3 Europe Hematology Controls and Calibrators Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hematology Controls and Calibrators Market Facts & Figures by Region
3.6.1 Asia Pacific Hematology Controls and Calibrators Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hematology Controls and Calibrators Sales by Region (2021–2032)
3.6.3 Asia Pacific Hematology Controls and Calibrators Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hematology Controls and Calibrators Market Facts & Figures by Country
3.7.1 Latin America Hematology Controls and Calibrators Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hematology Controls and Calibrators Sales by Country (2021–2032)
3.7.3 Latin America Hematology Controls and Calibrators Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hematology Controls and Calibrators Market Facts & Figures by Country
3.8.1 Middle East and Africa Hematology Controls and Calibrators Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hematology Controls and Calibrators Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hematology Controls and Calibrators Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hematology Controls and Calibrators Sales by Type (2021–2032)
4.1.1 Global Hematology Controls and Calibrators Sales by Type (2021–2026)
4.1.2 Global Hematology Controls and Calibrators Sales by Type (2027–2032)
4.1.3 Global Hematology Controls and Calibrators Sales Market Share by Type (2021–2032)
4.2 Global Hematology Controls and Calibrators Revenue by Type (2021–2032)
4.2.1 Global Hematology Controls and Calibrators Revenue by Type (2021–2026)
4.2.2 Global Hematology Controls and Calibrators Revenue by Type (2027–2032)
4.2.3 Global Hematology Controls and Calibrators Revenue Market Share by Type (2021–2032)
4.3 Global Hematology Controls and Calibrators Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hematology Controls and Calibrators Sales by Application (2021–2032)
5.1.1 Global Hematology Controls and Calibrators Sales by Application (2021–2026)
5.1.2 Global Hematology Controls and Calibrators Sales by Application (2027–2032)
5.1.3 Global Hematology Controls and Calibrators Sales Market Share by Application (2021–2032)
5.2 Global Hematology Controls and Calibrators Revenue by Application (2021–2032)
5.2.1 Global Hematology Controls and Calibrators Revenue by Application (2021–2026)
5.2.2 Global Hematology Controls and Calibrators Revenue by Application (2027–2032)
5.2.3 Global Hematology Controls and Calibrators Revenue Market Share by Application (2021–2032)
5.3 Global Hematology Controls and Calibrators Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bio-Rad
6.1.1 Bio-Rad Company Information
6.1.2 Bio-Rad Description and Business Overview
6.1.3 Bio-Rad Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bio-Rad Hematology Controls and Calibrators Product Portfolio
6.1.5 Bio-Rad Recent Developments/Updates
6.2 Streck
6.2.1 Streck Company Information
6.2.2 Streck Description and Business Overview
6.2.3 Streck Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Streck Hematology Controls and Calibrators Product Portfolio
6.2.5 Streck Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Thermo Fisher Scientific Hematology Controls and Calibrators Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 Randox Laboratories
6.4.1 Randox Laboratories Company Information
6.4.2 Randox Laboratories Description and Business Overview
6.4.3 Randox Laboratories Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Randox Laboratories Hematology Controls and Calibrators Product Portfolio
6.4.5 Randox Laboratories Recent Developments/Updates
6.5 Sysmex
6.5.1 Sysmex Company Information
6.5.2 Sysmex Description and Business Overview
6.5.3 Sysmex Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sysmex Hematology Controls and Calibrators Product Portfolio
6.5.5 Sysmex Recent Developments/Updates
6.6 Fortress Diagnostics
6.6.1 Fortress Diagnostics Company Information
6.6.2 Fortress Diagnostics Description and Business Overview
6.6.3 Fortress Diagnostics Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Fortress Diagnostics Hematology Controls and Calibrators Product Portfolio
6.6.5 Fortress Diagnostics Recent Developments/Updates
6.7 Bio-Techne
6.7.1 Bio-Techne Company Information
6.7.2 Bio-Techne Description and Business Overview
6.7.3 Bio-Techne Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bio-Techne Hematology Controls and Calibrators Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
6.8 Diatron
6.8.1 Diatron Company Information
6.8.2 Diatron Description and Business Overview
6.8.3 Diatron Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Diatron Hematology Controls and Calibrators Product Portfolio
6.8.5 Diatron Recent Developments/Updates
6.9 Changchun DIRUI
6.9.1 Changchun DIRUI Company Information
6.9.2 Changchun DIRUI Description and Business Overview
6.9.3 Changchun DIRUI Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Changchun DIRUI Hematology Controls and Calibrators Product Portfolio
6.9.5 Changchun DIRUI Recent Developments/Updates
6.10 Shenzhen Mindray
6.10.1 Shenzhen Mindray Company Information
6.10.2 Shenzhen Mindray Description and Business Overview
6.10.3 Shenzhen Mindray Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shenzhen Mindray Hematology Controls and Calibrators Product Portfolio
6.10.5 Shenzhen Mindray Recent Developments/Updates
6.11 Sichuan ZCMT
6.11.1 Sichuan ZCMT Company Information
6.11.2 Sichuan ZCMT Description and Business Overview
6.11.3 Sichuan ZCMT Hematology Controls and Calibrators Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sichuan ZCMT Hematology Controls and Calibrators Product Portfolio
6.11.5 Sichuan ZCMT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hematology Controls and Calibrators Industry Chain Analysis
7.2 Hematology Controls and Calibrators Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hematology Controls and Calibrators Production Mode & Process Analysis
7.4 Hematology Controls and Calibrators Sales and Marketing
7.4.1 Hematology Controls and Calibrators Sales Channels
7.4.2 Hematology Controls and Calibrators Distributors
7.5 Hematology Controls and Calibrators Customer Analysis
8 Hematology Controls and Calibrators Market Dynamics
8.1 Hematology Controls and Calibrators Industry Trends
8.2 Hematology Controls and Calibrators Market Drivers
8.3 Hematology Controls and Calibrators Market Challenges
8.4 Hematology Controls and Calibrators Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hematology Controls and Calibrators market is projected to grow from US$ 475 million in 2025 to US$ 719 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 159
USD 4900.00
(Single User License)
The global Hematology Controls and Calibrators market size was US$ 475 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 93
USD 4250.00
(Single User License)
The global market for Hematology Controls and Calibrators was estimated to be worth US$ 475 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 123
USD 3950.00
(Single User License)
The global Hematology Controls and Calibrators market is projected to grow from US$ 475 million in 2025 to US$ 681 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Published Date: 2025-07-04
Pages: 149
USD 4900.00
(Single User License)
The global market for Hematology Controls and Calibrators was valued at US$ 447 million in the year 2024 and is projected to reach a revised size of US$ 681 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published Date: 2025-07-04
Pages: 90
USD 2900.00
(Single User License)
The global Hematology Controls and Calibrators market size was US$ 447 million in 2024 and is forecast to a readjusted size of US$ 681 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-07-04
Pages: 94
USD 4250.00
(Single User License)
The global market for Hematology Controls and Calibrators was estimated to be worth US$ 447 million in 2024 and is forecast to a readjusted size of US$ 681 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-07-04
Pages: 120
USD 3950.00
(Single User License)
The global Hematology Controls and Calibrators market is projected to grow from US$ 475 million in 2025 to US$ 719 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 159
The global Hematology Controls and Calibrators market size was US$ 475 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 93
The global market for Hematology Controls and Calibrators was estimated to be worth US$ 475 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 123
The global Hematology Controls and Calibrators market is projected to grow from US$ 475 million in 2025 to US$ 681 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Published: 2025-07-04
Pages: 149
The global market for Hematology Controls and Calibrators was valued at US$ 447 million in the year 2024 and is projected to reach a revised size of US$ 681 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-07-04
Pages: 90
The global Hematology Controls and Calibrators market size was US$ 447 million in 2024 and is forecast to a readjusted size of US$ 681 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-07-04
Pages: 94
The global market for Hematology Controls and Calibrators was estimated to be worth US$ 447 million in 2024 and is forecast to a readjusted size of US$ 681 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-07-04
Pages: 120
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now